Aurobindo Pharma | Spese Operative



Operating Expenses Cambiamento Data
Cipla INR 53.64B 164.8M 2024-12
Dr.Reddys Laboratories INR 64.87B 1.28B 2024-12
Hindustan Unilever INR 121.74B 4.02B 2025-03
Sun Pharmaceuticals INR 104.3B 3.51B 2024-12
UPL INR 95.09B 7.11B 2024-12



Aurobindo Pharma Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.